Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion description "[Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion evidence source_evidence_literature NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion SIO_000772 24877854 NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion wasDerivedFrom befree-2016 NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_assertion wasGeneratedBy ECO_0000203 NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.
- befree-2016 importedOn "2016-02-19" NP1186837.RA_rauL2yQbdJUfM8iGq7nAN7Vlznu3vNHDs2zvww_41I130_provenance.